A phase II study of patupilone in patients (pts) with metastatic castration-resistant prostate cancer (CRPC) who have progressed after docetaxel

被引：0

作者：

Beardsley, E. K.

Saad, F.

Eigl, B.

Venner, P.

Hotte, S.

Winquist, E.

Ko, Y. J.

Sridhar, S. S.

Chi, K. N.

机构：

[1] BCCA Vancouver, Vancouver, BC, Canada

[2] Univ Montreal, Montreal, PQ, Canada

[3] Tom Baker Canc Clin, Calgary, AB, Canada

[4] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada

[5] Juravinski Canc Ctr, Hamilton, ON, Canada

[6] London Hlth Sci Ctr, London, ON, Canada

[7] Sunnybrook Canc Ctr, Toronto, ON, Canada

[8] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5139

引用

页数：2